NCT04055961

Brief Summary

The Atrial Fibrillation Ablation Registry (AFib Ablation Registry™) is designed to assess the prevalence, demographics, management, and outcomes of patients undergoing percutaneous catheter ablation procedures to treat atrial fibrillation (AF).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 20, 2019

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 8, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 14, 2019

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2025

Completed
Last Updated

February 28, 2023

Status Verified

February 1, 2023

Enrollment Period

6 years

First QC Date

August 8, 2019

Last Update Submit

February 27, 2023

Conditions

Atrial Fibrillation

Outcome Measures

Primary Outcomes (1)

  • Unsuccessful treatment rate

    measured by the number of repeated procedure

    1 year

Secondary Outcomes (1)

  • Adverse Events

    1 year

Interventions

Atrial Fibrillation AblationDEVICE

A procedure used to treat an irregular heart rhythm (arrhythmia)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients, 18 years and older, undergoing percutaneous catheter ablation procedures to treat atrial fibrillation

You may qualify if:

  • Adult patients
  • years and older
  • Undergoing percutaneous catheter ablation procedures to treat atrial fibrillation

You may not qualify if:

  • \. none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hoah Memorial Hospital Presbyterian

Newport Beach, California, 92663, United States

RECRUITING

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Leila Andres

    Hoag Memorial Hospital Presbyterian

    STUDY CHAIR

Central Study Contacts

Colleen Balius

CONTACT

9497641497colleen.balius@hoag.org

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
OTHER
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Data Coordinator

Study Record Dates

First Submitted

August 8, 2019

First Posted

August 14, 2019

Study Start

May 20, 2019

Primary Completion

May 20, 2025

Study Completion

May 20, 2025

Last Updated

February 28, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations

US(1)